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ABSTRACT 
Objective: Drugs prescribed in pregnancy may diffuse across the placenta to the fetus thereby posing a great risk of teratogenicity. In this study, 
drug utilization pattern in pregnancy amongst inpatient and outpatient groups was studied retrospectively in a specialist hospital in the North 
Western region of Nigerian.  
Methods: Drug prescription information was collected from case notes of 2634 patients that attended the antenatal clinic on an outpatient basis 
and those that were admitted due to complication(s) for a period of six months. Data collected were analyzed using Microsoft excel software and 
compared with FDA pregnancy categorization of drugs.  
Results: In the outpatient group, 215 patients had complaints that warranted the use of prescription drugs while in the inpatient group, 69 patients 
had complications that necessitated hospitalisation. In the outpatient group, prescribed drugs for the treatment of malaria (34%) and urinary tract 
infection (25%) were predominantly from FDA category B. In the inpatient group, drugs for malaria (18%), anemia (11.6%) and pre-eclampsia 
(11.6%) were the most prescribed. In the management of anemia, drugs prescribed were purely from FDA category A, while, in the case of pre-
eclampsia, a significant amount of prescribed drugs were from FDA categories C and N.  
Conclusion: In both patient groups, no drug from FDA category X was prescribed. Therefore, it can be concluded that drugs prescribed in pregnancy 
in specialist hospital, Sokoto-Nigeria, were within a reasonable limit of safety. However, the use of drugs such as diazepam whose risks are yet to be 
classified should be avoided. 
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Regardless of the limited information on safety, the use of drugs in 
pregnancy is common in medical practice [1]. Drugs are commonly 
prescribed in pregnancy for conditions of deficiency directly related 
to pregnancy such as supplementation with drugs like iron, folic 
acid, calcium, and vitamins in the management of anemia, or for the 
treatment of conditions secondary to pregnancy such as urinary 
tract infection, eclampsia and many more.  
Drugs are also used in pregnancy to treat pre-existing chronic conditions 
such as diabetes, epilepsy and hypertension [2]. Due to placental 
transport of maternal substrate to the fetus, substances of low molecular 
weight including drugs can diffuse freely across the placenta to fetus [3]. 
Therefore, the use of drugs in pregnancy is an issue of great concern to 
the patients as well as prescribers [2]. This assertion is proven true by 
previous incidences of teratogenicity in the past, for example, the 
thalidomide and diethylstilbestrol incidences of 1960 and 1971, 
respectively. Also, it has been reported that medicines are responsible 
for 1% of reported cases of congenital malformations [4].  
Often, due to ethical reasons, manufacturers of pharmaceuticals almost 
never screen new drugs for safety in pregnant women. Moreover, results 
of safety from the animal study are not always extrapolated in human 
population. These constraints often compel manufacturers of 
pharmaceuticals to label most drugs as ‘contraindicated in pregnancy’ 
or ‘use in pregnancy is not recommended unless potential benefits 
outweigh potential risk to fetuses’ [5]. 
In view of this challenge, many regulatory bodies across the world have 
classified drugs into various pregnancy categories based on available 
evidence of risks or harmful effects associated with their use in 
pregnancy. Notable amongst these are Food and Drug Administration 
categorization [6]; Australian categorization; German categorization and 
many more. These categorizations are aimed at guiding health 
professions in the selection of prescription drugs for use in pregnancy. 
Drugs used in pregnancy, in the FDA and German categorization, are 
grouped based on their hierarchy of risk with increasing order of risk 
down the table while Australian categorization is independent on the 
hierarchy of risk to cause defects to fetuses.  
However, it is recommended that drugs that have been in use for a 
long period of time should be encouraged to be prescribed during 
pregnancy at possibly lower end of therapeutic dose range. 
This research work is an investigation into drug utilization pattern in 
pregnancy amongst inpatient and outpatient groups at the Obstetrics 
and Gynecology Department of a specialist hospital in North Western 
Nigeria. It aims at creating useful research data that will promote safe 
and effective use of medicines in pregnancy by health practitioners in 
North Western Nigeria and thereby improving overall health outcome. It 
is aimed at putting together information on drug prescription practices 
and prevalent complaints that warrant the use of the drug(s) in 
pregnancy from in and out patients’ case folders and evaluating the 
degree of adherence of these prescriptions to standard 
recommendations by FDA. 
MATERIALS AND METHODS  
This study, retrospective in nature, was carried out at the antenatal clinic 
(ANC) of the Obstetrics and Gynecology Department of Specialist 
Hospital, Sokoto-Nigeria. It covers a period of 6 mo (January to June 
2008). Drug prescription information was collected from case notes of 
pregnant women that attended the antenatal clinic on an outpatient 
basis (outpatient group) and those that were eventually admitted in the 
hospital as a result of complications (inpatient group). A total of 2634 
folders were reviewed for the ANC during the study period. 215 patients 
had complaints that warranted the use of prescription drugs while 69 
were admitted due to complaints of complications relating to pregnancy. 
The drugs used in both groups were classified according to diagnosis 
and evaluated in comparison with FDA categorization. The prevalent 
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causes of hospitalisation during pregnancy and frequency of pregnancy across ages were also evaluated. 
 
Table 1: FDA pregnancy categorization of medicines 
Category Description Examples 
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus  Levothyroxine, folic acid, magnesium 
sulfate, liothyronine 
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no 
adequate and well-controlled studies in pregnant women.  
 Levothyroxine, folic acid, magnesium 
sulfate, liothyronine 
C Animal reproduction studies have shown an adverse effect on the fetus and no adequate studies 
in humans, but the potential benefit may warrant use in pregnancy despite potential risks.  
 Tramadol, gabapentin, amlodipine, 
trazodone, prednisolone 
D There is positive evidence of human fetal risk, but the potential benefit may warrant use in 
pregnancy despite potential risks.  
Lisinopril, alprazolam, losar-tan, 
clonazepam, lorazepam 
X Positive fetal abnormalities and risks involved in the use of the drug in pregnant women 
clearly outweigh potential benefits.  
 Atorvastatin, simvastatin, warfarin, 
methotrexate 
N FDA has not yet classified the drug into a specified pregnancy category.  Aspirin, oxycodone, acetaminophen, 
diazepam 
FDA = United States Food and Drug Administration and Control 
 
Ethics committee approval 
The Institutional Ethics Committee permission was taken prior to 
the commencement of the study.  
Hospital background 
The study was conducted at the Department of Obstetrics and 
Gynecology of the Specialist Hospital, Sokoto-Nigeria. The hospital is a 
600-bed tertiary care hospital, which receives referrals from other 
private clinics, hospitals and general Physicians. It comprises of 13 
departments under the stewardship of an experienced Medical Director. 
Prescription practices  
Pregnant women who attended the ANC were examined by a team of 
general practicing, consultant physicians and house surgeons of the 
department, and were given hand-written prescriptions. Pregnant 
women obtained their drugs either from hospital pharmacy or 
registered pharmacies outside the hospital when they are out-of-
stock in the hospital. There was no facility to maintain pregnant 
women’s health records electronically in the hospital.  
Inclusion criteria  
All pregnant patients greater than or equal to 11yrs of age were 
enrolled, via convenience sampling, in any trimester. All patients 
attending antenatal outpatient clinics or on admission in the ward, 
with or without co-morbidities and within the period of study were 
included in the study.  
Exclusion criteria  
Poorly legible prescriptions, without signature and date, pregnant 
women diagnosed with acute and chronic medical conditions not 
secondary to pregnancy that require hospitalization were excluded 
from the study. 
Statistical analysis 
Data collected were analyzed and presented as graphs using 
descriptive statistics with the help of Excel software, Microsoft office 
2007. 
RESULTS 
At the end of this study, a total number of 2634 cases of pregnancy 
were recorded. 215 (8.2%) outpatients and 69 (2.6%) inpatients 
presented with conditions that necessitated prescription of drugs. In 
both groups, age group 21-30 presented the highest number of cases 
with prescription (fig. 1). 
Malaria was the most common cause of prescription constituting 
18.8 and 34.4 % of the overall prescriptions in the inpatient and 
outpatient groups, respectively (fig. 2 and 3). In the inpatient group, 
in line with United States FDA categorization, 86% and 14 % of 
prescribed medicines for malaria were from categories B and C, 
respectively, while 70 and 30% of medicines prescribed for 
threatened abortion were from categories B and N, respectively. 
 
Fig. 1: Frequencies of pregnancy in different age groups 
amongst inpatient and outpatient groups 
 
 
Fig. 2: Frequencies of prescription according to diagnosis 
amongst outpatient group, UTI; urinary tract infection, URTI; 
upper respiratory tract infection, CTS; Carpel Tunnel’s syndrome 
 
 
Fig. 3: Frequencies of prescription according to diagnosis 
amongst inpatient group, IA; incomplete abortion, UTI; urinary 
tract infection 
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For UTI, 42.9 and 57.1 of drugs prescribed were grouped into 
categories B and C, respectively, while for severe anemia, 100% of 
prescribed drugs were from category A. For Pre-eclampsia, 84.21 
and 15.79% of prescribed drugs belong to category C and N, 
respectively. For eclampsia, 18.8%, 16.6%, 45.8% and 18.8% of 
medicines prescribed were from categories A, B, C and N, 
respectively. For gastroenteritis, equal amount (50%) of prescribed 
medicines were drawn from categories B and C (fig. 4). 
In the outpatient group, 82.4 % and 17.6 % of prescribed medicines 
for malaria were from categories B and C, respectively while 86.6 % 
and 13.4% medicines prescribed for candidiasis were from categories 
B and C, respectively. 86.8 and 13.2 % of medicines prescribed for UTI 
were from categories B and C, respectively. For gastritis, 100% of 
prescribed medicines were from category B while 72.2 and 27.8% of 
prescribed medicines for hypertension were from categories B and C, 
respectively. 66.7 and 33.3% of prescriptions for body ache were from 
categories B and C, respectively. 83.4 and 16.6 % of medicines 
prescribed for URTI were from categories B and C, respectively while 
33.4 and 66.6 % of medicines for dysentery were from categories B 
and C, respectively. For insomnia, 66.7 and 33.3 % of the medicines 
prescribed were from categories B and N, respectively while in the 
case of carpel Tunnel’s syndrome, prescribed medicines were equally 
distributed between categories A and B (fig. 5). 
 
 
Fig. 4: Percentage prescription according to FDA categories 
amongst inpatient group, TA; Threatened abortion, UTI; 
urinary tract infection 
 
 
Fig. 5: Percentage prescription according to FDA categories 
amongst outpatient group, UTI; urinary tract infection, URTI; upper 
respiratory tract infection, CTS; Carpel-Tunnel’s syndrome 
 
DISCUSSION  
In as much as drugs play an important role in improving and 
promoting the overall well-being of Mankind, it is expected that they 
are safe when used [4]. Previous studies carried out by WHO [7], 
Tsega et al. [8], Abubakar et al. [9], Ilyaz et al. [10] and many more 
researchers have shown that drugs are commonly used in pregnancy 
for the management of different medical conditions. Because the 
health of both the mother and fetus is at stake, drug use in 
pregnancy requires special consideration of safety in addition to 
efficacy [8]. At the end of this study, it was revealed that the nature 
of diagnosis that warrants the use of drugs in pregnancy varies 
between inpatient and outpatient groups. Malaria, candidiasis, UTI, 
gastritis, hypertension, body ache, URTI, dysentery, insomnia and 
CTS were found to be the common medical conditions that 
necessitated the use of medicines in the outpatient group while 
severe malaria, threatened abortion, severe anemia, preeclampsia, 
eclampsia, Batholin cyst and gastroenteritis were the diagnosis that 
necessitated hospitalization and use of drugs in the inpatient group. 
In the outpatient group, 215 (8.2%) patients received prescriptions 
while in the inpatient group only 69 (2.6%) of patients received 
medication. This discrepancy could be accounted for by the nature of 
diagnosis in the inpatient group, as it requires a specialized choice of 
drugs on the basis of safety and efficacy [11]. In the outpatient 
group, with the exception of supplement such as folic acid, iron and 
vitamins, the commonly prescribed drugs were for malaria (34.4%) 
and UTI (24.7%). Contrarily, in the inpatient group, other than 
malaria medication (18.8%), medication for severe anemia and pre-
eclampsia (11.6% each) were also significantly prescribed. Drugs for 
the management of incomplete abortion also constituted 18.8% of 
prescriptions in this group. Because in this case, the fetuses were 
already lost, it was excluded from the analysis. Thus, antimalarial 
drugs constituted the most frequently prescribed drugs in both inpatient 
and outpatient groups. This could be partly accounted for by the fact 
that, in Sub-Saharan Africa, the prevalence of parasitic diseases such as 
malaria is high due to poor sanitary condition and control [12]. 
Chloroquine, artesunate and pyrimethamine-sulphadoxine combination 
(fansidar) were the most prescribed antimalarial drugs. These drugs 
belong to FDA category B and are known for their attributes of safety in 
pregnancy. On the ground of resistance of Plasmodium falciparum 
malaria to chemotherapeutic agents, the Federal Ministry of Health of 
Nigeria has withdrawn the use of chloroquine as a first line treatment for 
both complicated and uncomplicated malaria. However, it is still widely 
prescribed by many practitioners in Nigeria on the ground that 
significant treatment success is still achievable with Chloroquine. In the 
treatment of UTI, amoxicillin (50.9%) and metronidazole (34%) were 
the most prescribed antibiotics in both inpatient and outpatient groups 
while, in the treatment of severe anemia, ferrotone (iron, vit. B12 and C) 
and folic acid were the most prescribed drugs. These drugs belong to 
FDA category A. In the treatment of pre-eclampsia, eclampsia and 
threatened abortion, diazepam constituted15.8 %, 18.8 % and 30 % 
prescribed drugs, respectively. These percentages were significantly 
high as diazepam is yet to be classified into any risk category (category 
N) and is, therefore, likely to pose a higher risk to the fetus.  
Summarily, except in the treatment of CTS in which 50% of 
prescribed drugs were from FDA category A, prescribed drugs in the 
outpatient group were mainly from categories B and C. FDA 
Category A is known to be constituted of drugs in which adequate 
and well-controlled studies have failed to demonstrate a risk to the 
fetus while category B comprises of drugs in which animal 
reproduction studies have failed to demonstrate a risk to the fetus 
and there are no adequate and well-controlled studies in pregnant 
women. Category C comprises of drugs in which animal 
reproduction studies have shown an adverse effect on the fetus and 
no adequate studies in humans, but the potential benefit may 
warrant use in pregnancy despite potential risks (table 1). However, 
in the management of insomnia in the outpatient group, 33.3% of 
prescribed drugs were from FDA category N. This category 
comprises of drugs that are yet to be categorized by FDA and may 
thus possess higher risk potential.  
In the inpatient group, except for treatment of severe anemia, 
malaria and gastroenteritis in which drugs prescribed were mainly 
from categories A and B, prescriptions for other diagnosis were 
largely drawn from drugs across categories B and C. This could 
probably be because of the nature of medical conditions that 
warranted hospitalization and the specialist prescription 
requirement. Therefore, this group appears to be more prone to 
higher risk of adverse drug reaction and teratogenicity than the 
outpatient group. 
Limitation 
This study only covered a part of a state in the Northwest region of 
Nigeria for a period of 6 mo, therefore, cannot be extrapolated to 
other regions of the country.  
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With respect to FDA categorization, it can be concluded that drugs 
prescribed to the pregnant patient in Specialist Hospital, Sokoto-
Nigeria, are within reasonable limit of safety. However, as regards 
management of threatened abortion, insomnia, pre-eclampsia and 
eclampsia, the use of drugs such as Diazepam, which belong to FDA 
category N and are yet to be classified may pose a higher risk of 
teratogenicity to the fetus and should, therefore, be replaced with 
alternatives with well-established safety profile. In addition, the 
percentage of fetal loss, as shown in the fraction of incomplete 
abortion (18.8%), was relatively high. Therefore, investigative 
researches should be conducted in this area in order to unravel the 
background cause(s) and proffer preventive solution. 
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